Showing results (3301-3310 of 25,889) with videos related to

Sort By:
Pageof 2,589
Anticancer Research|April 12, 2003
Immunohistochemical expression and prognostic significance of FAS and GLUT1 in bladder carcinomaPaolo Visca, Valeria Sebastiani, Ellen S Pizer, et al.
Anticancer Research|April 12, 2003
Down-regulated expression of the CCAAT/enhancer binding protein alpha and beta genes in human hepatocellular carcinoma: a possible prognostic markerMinoru Tomizawa, Kazuo Watanabe, Hiromitsu Saisho, et al.
Anticancer Research|April 12, 2003
Anticancer potential of curcumin: preclinical and clinical studiesBharat B Aggarwal, Anushree Kumar, Alok C Bharti
Anticancer Research|April 12, 2003
Efficiency of amifostine as a protection against doxorubicin toxicity in rats during a 12-day treatmentP Nazeyrollas, C Frances, A Prevost, et al.
Anticancer Research|April 12, 2003
Comparison of daunomycin effects on human keratinocytes and melanoma HTB 1410 cells. Image cytometry studyJustyna Drukala, Bartlomiej Rajwa, Zbigniew Pietrzkowski, et al.
Anticancer Research|April 12, 2003
Different expression of Fas and Fas ligand in tumor infiltrating and peripheral lymphocytes of patients with renal cell carcinomasUrsula Elsässer-Beile, Dorothee Gierschner, Tanja Welchner, et al.
Anticancer Research|April 12, 2003
Aspirin and methylsulfonylmethane (MSM): a search for common mechanisms, with implications for cancer preventionKaney Ebisuzaki
Anticancer Research|April 12, 2003
All-trans-retinoic acid activates caspase-1 in a dose-dependent manner in cervical squamous carcinoma cellsIstvan Arany, Istvan A Ember, Stephen K Tyring
Anticancer Research|June 25, 2003
Pro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE), carcinoembryonic antigen (CEA) and cytokeratin 19-fragments (CYFRA 21-1) in patients with lung cancer in comparison to other lung diseasesJoachim Schneider, Monika Philipp, Hans-Georg Velcovsky, et al.
Anticancer Research|June 25, 2003
Normalisation of biochemical markers of bone formation correlates with clinical benefit from therapy in metastatic breast cancerD Lüftner, A Richter, R Geppert, et al.
Pageof 2,589